* Xenetic Biosciences Inc XBIO.OQ XBIO.O is expected
to show a
fall in quarterly revenue when it reports results on August 9
(estimated) for the period ending June 30 2024
* The Framingham Massachusetts-based company is expected to
report a 17.1% decrease in revenue to $540 thousand from $651.01
thousand a year ago, according to the estimate from one analyst,
based on LSEG data.
* LSEG's mean analyst estimate for Xenetic Biosciences Inc
is for
a loss of 83 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated August 7 at 14:57 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)